Covaxin has 50% effectiveness against symptomatic Covid-19, says first real-world study
Covaxin is a Vero cell-derived, inactivated whole-virion vaccine formulated with a novel adjuvant Bharat Biotech’s Covaxin is 50 per cent effective as a vaccine against symptomatic Covid-19 infection, says a study conducted on AIIMS, New Delhi hospital workers during the second wave surge in India. The study, first of its kind of the effectiveness of … Read more